DrugPatentWatch Database Preview
Septodont Holding Company Profile
What is the competitive landscape for SEPTODONT HOLDING, and what generic alternatives to SEPTODONT HOLDING drugs are available?
SEPTODONT HOLDING has one approved drug.
There are five US patents protecting SEPTODONT HOLDING drugs.
Summary for Septodont Holding
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Septodont Holding
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | 6,872,390 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | 7,229,630 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | 7,569,230 | ➤ Sign Up | ➤ Sign Up | ||||
| Septodont Holding | ORAVERSE | phentolamine mesylate | INJECTABLE;INJECTION | 022159-001 | May 9, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Septodont Holding Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2005211689 | ➤ Sign Up |
| Mexico | PA04012507 | ➤ Sign Up |
| Spain | 2281418 | ➤ Sign Up |
| Japan | 4787977 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
